What it sells
First ECG AI to go beyond diagnostics and recommend treatment
Business model breakdown
Buyer: who owns the budget?
UnverifiedCardiology practices and clinicians; also device/digital health companies licensing the AI.
Workflow: what inputs become what output?
Clinician reviews ECG from third-party FDA-cleared devices (mobile ECG, mobile cardiac telemetry, implantable monitor) in a phone-based platform with explainable AI and patient-specific treatment steps for remote therapeutic monitoring.
Distribution: how it reaches customers
Partnership/inquiry-led (Get in touch); software also offered to power partner products.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2021 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.